story of the week
Improved Efficacy of Palbociclib vs Chemotherapy for the Treatment of Postmenopausal Women With HR+/HER2− Advanced/Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Systematic Review and Network Meta-Analysis Comparing Palbociclib With Chemotherapy Agents for the Treatment of Postmenopausal Women With HR-Positive and HER2-Negative Advanced/Metastatic Breast Cancer
Breast Cancer Res Treat 2017 Jul 27;[EPub Ahead of Print], FR Wilson, A Varu, D Mitra, C Cameron, S IyerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.